Scientific work

Uzm. Dr. Cavid Baba

43 publications. The source of the information is stated next to each publication.

Back to profile

  1. The Relationship Between Retinal Layer Thickness and Cognition in People with Multiple Sclerosis

    Journal of Multiple Sclerosis Research, 2025

    DOI 10.4274/jmsr.galenos.2024.2024-12-1 Source: ORCID

  2. Evaluation of the effect of cervical cord lesion on upper extremity function in newly diagnosed persons with multiple sclerosis running head: upper extremity function in multiple sclerosis

    Ege Tıp Dergisi, 2025

    DOI 10.19161/etd.1604450 Open-access full textSource: ORCID

  3. Revisiting the diagnostic marker: Oligoclonal band positivity is not associated with early disability or cognitive performance in relapsing-remitting multiple sclerosis.

    Multiple sclerosis and related disorders, 2025

    DOI 10.1016/j.msard.2025.106727 PMID 40975016 Source: ORCID

  4. Effect of the synchronized telerehabilitation-based upper extremity training program on hand-arm functions in people with multiple sclerosis

    Multiple Sclerosis and Related Disorders, 2025

    DOI 10.1016/j.msard.2025.106438 PMID 40262472 1 citation (Europe PMC) Source: ORCID

  5. Tracking Walking Capacity in People with Multiple Sclerosis Without Disability: 3-year Follow-up of Objective and Subjective Gait Measures

    Journal of Multiple Sclerosis Research, 2025

    DOI 10.4274/jmsr.galenos.2025.2025-3-3 Open-access full textSource: OpenAlex

  6. Cognition as a parameter in monitoring the effect of multiple sclerosis relapse treatment: A prospective controlled study

    Clinical Neurology and Neurosurgery, 2024

    DOI 10.1016/j.clineuro.2024.108173 PMID 38430729 Open-access full textSource: ORCID

  7. Effect of Telerehabilitation-Based Motor Imagery Training on Pain and Related Factors in People with Multiple Sclerosis: Randomized Controlled Pilot Trial

    Archives of Physical Medicine and Rehabilitation, 2024

    DOI 10.1016/j.apmr.2024.10.009 PMID 39489207 5 citations (Europe PMC) Source: ORCID

  8. Risk of hepatitis B virus reactivation in people with multiple sclerosis treated with ocrelizumab: an observational study from Turkey

    Journal of Neurology, 2024

    DOI 10.1007/s00415-024-12333-0 PMID 38578494 5 citations (Europe PMC) Open-access full textSource: ORCID

  9. Discriminative ability of the original and short form of the Activities-specific Balance Confidence scale and its individual items for falls in people with multiple sclerosis

    Acta Neurologica Belgica, 2024

    DOI 10.1007/s13760-024-02515-y PMID 38483733 3 citations (Europe PMC) Open-access full textSource: ORCID

  10. Is disease-modifying therapy use in multiple sclerosis a risk factor during the COVID-19 pandemic? A large cohort study

    Journal of Health Policy & Outcomes Research, 2024

    DOI 10.7365/jhpor.2024.1.5 1 citation (OpenAlex) Open-access full textSource: ORCID

  11. Predictors of relapse severity in multiple sclerosis

    Acta Neurologica Belgica, 2024

    DOI 10.1007/s13760-023-02456-y PMID 38238606 Source: ORCID

  12. COVID-19 vaccine response in Neuromyelitis Optica Spectrum Disorder

    Clinical Neurology and Neurosurgery, 2024

    DOI 10.1016/j.clineuro.2024.108152 PMID 38382130 Source: ORCID

  13. What might the COVID‐19 pandemic in regard to people with neuromyelitis optica spectrum disorder teach us regarding the future?

    Clinical and Experimental Neuroimmunology, 2024

    DOI 10.1111/cen3.12769 1 citation (OpenAlex) Open-access full textSource: ORCID

  14. Comparative analysis of cognitive and physical characteristics in late-onset, adult-onset and early-onset multiple sclerosis patients

    Multiple Sclerosis and Related Disorders, 2024

    DOI 10.1016/j.msard.2024.105810 PMID 39180837 3 citations (OpenAlex) Source: OpenAlex

  15. Feasibility of exergaming for upper extremity rehabilitation in people with multiple sclerosis: prospective clinical trial

    Acta Neurologica Belgica, 2024

    DOI 10.1007/s13760-024-02556-3 PMID 38669001 2 citations (OpenAlex) Open-access full textSource: OpenAlex

  16. The comparative effectiveness of fingolimod, natalizumab, and ocrelizumab in relapsing-remitting multiple sclerosis

    Neurological Sciences, 2023

    DOI 10.1007/s10072-023-06608-z PMID 36689010 17 citations (Europe PMC) Open-access full textSource: ORCID

  17. Comparative Analysis of Diagnostic Criteria for Radiologically Isolated Syndrome

    Neurology, 2023

    DOI 10.1212/wnl.0000000000203730 Open-access full textSource: ORCID

  18. Dual‐task difficulties as a risk factor for unemployment in people with multiple sclerosis

    Brain and Behavior, 2023

    DOI 10.1002/brb3.3299 PMID 37881143 6 citations (Europe PMC) Open-access full textSource: ORCID

  19. Feasibility of Telerehabilitation-Based Pelvic Floor Muscle Training for Urinary Incontinence in People With Multiple Sclerosis: A Randomized, Controlled, Assessor-Blinded Study.

    Journal of neurologic physical therapy : JNPT, 2023

    DOI 10.1097/npt.0000000000000448 PMID 37306430 11 citations (Europe PMC) Source: ORCID

  20. mRNA versus inactivated virus COVID-19 vaccines in multiple sclerosis: Humoral responses and protectivity-Does it matter?

    Multiple sclerosis and related disorders, 2023

    DOI 10.1016/j.msard.2023.104761 PMID 37247488 10 citations (Europe PMC) Open-access full textSource: ORCID

  21. Association of mRNA versus inactivated Covid-19 vaccine responses with smoking in Multiple Sclerosis

    Nöro Psikiyatri Arşivi, 2023

    DOI 10.29399/npa.28503 PMID 37645088 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  22. The Turkish experience of COVID-19 infection in people with NMOSD and MOGAD: A milder course?

    Multiple Sclerosis and Related Disorders, 2022

    DOI 10.1016/j.msard.2021.103399 PMID 35216782 6 citations (Europe PMC) Open-access full textSource: ORCID

  23. Three doses of COVID-19 vaccines in multiple sclerosis patients treated with disease-modifying therapies.

    Multiple sclerosis and related disorders, 2022

    DOI 10.1016/j.msard.2022.104119 PMID 36037755 4 citations (Europe PMC) Open-access full textSource: ORCID

  24. Epstein-Barr virus antibody in newly diagnosed multiple sclerosis patients and its association with relapse severity and lesion location

    Multiple Sclerosis and Related Disorders, 2022

    DOI 10.1016/j.msard.2022.104149 PMID 36096010 6 citations (Europe PMC) Source: ORCID

  25. Effects and safety of exergaming in persons with multiple sclerosis during corticosteroid treatment: a pilot study

    Multiple Sclerosis and Related Disorders, 2022

    DOI 10.1016/j.msard.2022.103823 PMID 35523062 13 citations (Europe PMC) Source: ORCID

  26. Self‐injectable DMTs in relapsing MS: NEDA assessment at 10 years in a real‐world cohort

    Acta Neurologica Scandinavica, 2022

    DOI 10.1111/ane.13582 PMID 35043388 2 citations (Europe PMC) Open-access full textSource: ORCID

  27. The Preference-Based Multiple Sclerosis Index: an assessment of its psychometric properties and translation into Turkish.

    Disability and rehabilitation, 2022

    DOI 10.1080/09638288.2022.2060340 PMID 35387534 1 citation (Europe PMC) Source: ORCID

  28. Relationship between presence of spinal cord lesion and restless legs syndrome in multiple sclerosis.

    Somatosensory & motor research, 2022

    DOI 10.1080/08990220.2022.2027360 PMID 35042439 8 citations (Europe PMC) Source: ORCID

  29. Challenges of persons with multiple sclerosis on ocrelizumab treatment during COVID‐19 pandemic

    Neurology and Clinical Neuroscience, 2022

    DOI 10.1111/ncn3.12561 PMID 34909197 5 citations (Europe PMC) Open-access full textSource: ORCID

  30. Comparison of SARS-CoV-2 antibody response after two doses of mRNA and inactivated vaccines in multiple sclerosis patients treated with disease-modifying therapies

    Multiple Sclerosis and Related Disorders, 2022

    DOI 10.1016/j.msard.2022.103486 PMID 35032878 19 citations (Europe PMC) Open-access full textSource: ORCID

  31. Prevalence and determinants of falls in persons with multiple sclerosis without a clinical disability

    Multiple Sclerosis and Related Disorders, 2021

    DOI 10.1016/j.msard.2021.102771 PMID 33493789 17 citations (Europe PMC) Source: ORCID

  32. Cross-cultural adaptation and psychometric properties of the Turkish version of the Manual Ability Measure-36 (MAM-36) in people with multiple sclerosis

    Neurological Sciences, 2021

    DOI 10.1007/s10072-020-04927-z PMID 33236246 4 citations (Europe PMC) Source: ORCID

  33. Five-year real-world data on fingolimod treatment's effects on cognitive function

    Multiple Sclerosis and Related Disorders, 2021

    DOI 10.1016/j.msard.2021.103089 PMID 34198030 7 citations (Europe PMC) Open-access full textSource: ORCID

  34. Restless legs syndrome and related factors in people with multiple sclerosis in Turkey

    Neurological Research, 2021

    DOI 10.1080/01616412.2021.2000822 PMID 34781840 1 citation (Europe PMC) Source: ORCID

  35. The outcome of a national MS-Covid-19 study: What the Turkish MS cohort reveals?

    Multiple Sclerosis and Related Disorders, 2021

    DOI 10.1016/j.msard.2021.102968 PMID 33940495 21 citations (Europe PMC) Open-access full textSource: ORCID

  36. The Association of Obesity with Walking and Balance Control in Fully Ambulatory People with Multiple Sclerosis According to Two Different Classifications

    Journal of Multiple Sclerosis Research, 2021

    DOI 10.4274/jmsr.galenos.2021.2021.8-2 4 citations (OpenAlex) Open-access full textSource: OpenAlex

  37. Challenges of Patients with Neuromyelitis Optica Spectrum Disorder During COVID-19 Pandemic

    Journal of Multiple Sclerosis Research, 2021

    DOI 10.4274/jmsr.galenos.2021.6-1 2 citations (OpenAlex) Source: OpenAlex

  38. Further Validity of the Short Version of the Activities-Specific Balance Confidence Scale in Patients with Multiple Sclerosis

    Journal of Multiple Sclerosis Research, 2021

    DOI 10.4274/jmsr.galenos.2021.6-4 2 citations (OpenAlex) Open-access full textSource: OpenAlex

  39. The Relationship Between Fatigue and Lower Extremity Function in People with Multiple clerosis with the Absence of Clinical Disability

    Journal of Multiple Sclerosis Research, 2021

    DOI 10.4274/jmsr.galenos.2021.6-3 Open-access full textSource: OpenAlex

  40. Effects of the Coronavirus Disease-2019 Pandemic on Physical Activity Level, Depression, and Anxiety in Persons with Multiple Sclerosis

    Journal of Multiple Sclerosis Research, 2021

    DOI 10.4274/jmsr.galenos.2021.2021.8-1 Open-access full textSource: OpenAlex

  41. Association Between Lower Limb Spasticity and Falls in Persons with Multiple Sclerosis

    Journal of Multiple Sclerosis Research, 2021

    DOI 10.4274/jmsr.galenos.2021.2021.8-4 Open-access full textSource: OpenAlex

  42. Rare Two Findings in Frontal Lobe Epilepsy: Finger Snapping, and Ictal Alpha Activity.

    Annals of Indian Academy of Neurology, 2020

    DOI 10.4103/aian.aian_329_20 PMID 34220080 Open-access full textSource: ORCID

  43. Explanatory factors of balance confidence in persons with multiple sclerosis: Beyond the physical functions

    Multiple Sclerosis and Related Disorders, 2020

    DOI 10.1016/j.msard.2020.102239 PMID 32512478 3 citations (Europe PMC) Source: ORCID